Kyntra Bio (KYNB) Research & Development (2014 - 2026)
Kyntra Bio's Research & Development came in at $6.82 million for Q2 2026, up 16.3% from $5.87 million a year earlier but down 9.8% from the prior quarter.
Kyntra Bio (KYNB) Research & Development (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kyntra Bio reported Research & Development of $22.86 million, down 45.4% year-over-year; for FY2025, it came in at $23.52 million, down 75.4% from FY2024.
- Research & Development has declined in each of the last four years, with a five-year compound annual growth rate of -37.8% (FY2020 to FY2025).
- Going back by year, Research & Development was $95.69 million in FY2024 (-64.1%), $266.47 million in FY2023 (-10.2%), $296.79 million in FY2022 (-23.3%) and $387.04 million in FY2021 (+53.0%).
- The five-year range for quarterly Research & Development is $1.21 million (Q3 2025) to $113.92 million (Q4 2021).
- Year-over-year, Research & Development increased in two of the last eight quarters, with an average decline of 49.3%.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 45.8%), and the weakest in Q3 2025 (a decline of 93.9%).
- Business Quant data shows KYNB's Research & Development at $7.57 million (Q1 2026), $7.27 million (Q4 2025) and $1.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Kyntra Bio | 21.25 Mn | -386.69 Mn | 1.47 Mn | 6.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.82 Mn |
| Mar 31, 2026 | 7.57 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 9.18 Mn |
| Dec 31, 2024 | 6.87 Mn |
| Sep 30, 2024 | 19.97 Mn |
| Jun 30, 2024 | 32.36 Mn |
| Mar 31, 2024 | 36.49 Mn |
| Dec 31, 2023 | 35.32 Mn |
| Sep 30, 2023 | 61.19 Mn |
| Jun 30, 2023 | 95.48 Mn |
| Mar 31, 2023 | 74.49 Mn |
| Dec 31, 2022 | 61.63 Mn |
| Sep 30, 2022 | 75.18 Mn |
| Jun 30, 2022 | 70.96 Mn |
| Mar 31, 2022 | 89.02 Mn |
| Dec 31, 2021 | 113.92 Mn |
| Sep 30, 2021 | 75.88 Mn |
Kyntra Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KYNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();